Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity

Neuroscience

Volumn 253, Issue , 2013, Pages 444-454

  Reich, C G ^a   Mihalik, G R ^a   Iskander, A N ^a   Seckler, J C ^a   Weiss, M S ^a  

^a RAMAPO COLLEGE OF NEW JERSEY   (United States)

Author keywords

CB1 receptor; Depression; Hippocampus; LTP

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; ENDOCANNABINOID; PICROTOXIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CHRONIC MILD STRESS; CHRONIC STRESS; CONTROLLED STUDY; ELECTRIC POTENTIAL; GABAERGIC TRANSMISSION; GLUTAMATERGIC NEUROTRANSMISSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS THETA RHYTHM; IN VITRO STUDY; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

2-AG; 2-ARACHIDONOYL-GLYCEROL; ACSF; AEA; ANALYSIS OF VARIANCE; ANOVA; ARTIFICIAL CEREBROSPINAL FLUID; CANNABINOID; CB; CB1 RECEPTOR; CCK; CHOLECYSTOKININ; CHRONIC MILD STRESS; CHRONIC RESTRAINT STRESS; CMS; CRS; DEPOLARIZATION-INDUCED-SUPPRESSION OF INHIBITION; DEPRESSION; DIMETHYL SULFOXIDE; DMSO; DSI; ECBS; ENDOCANNABINOID/ENDOVANNILOID ANANDAMIDE; ENDOCANNABINOIDS; GC; GLUCOCORTICOID; HIPPOCAMPUS; HPA; HYPOTHALAMIC-PITUITARY-ADRENAL; LONG-TERM-POTENTIATION; LTP; MANOVAS; MULTIVARIATE ANOVA; NON-STRESS; NS; PICROTOXIN; PND; POST NATAL DAY; POST-TRAUMATIC-STRESS-DISORDER; PTSD; PTX; S; STRESS; TBS; THETA-BURST STIMULATION;

ANIMALS; BENZOXAZINES; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA ANTAGONISTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MORPHOLINES; NAPHTHALENES; NEURONAL PLASTICITY; PICROTOXIN; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 84885343062     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.08.066     Document Type: Article

References (49)

1. Alfarez D.N., Joëls M., Krugers H.J. Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. Eur J Neurosci 2003, 17:1928-1934.
2. Bowles N.P., Hill M.N., Bhagat S.M., Karatsoreos I.N., Hillard C.J., McEwen B.S. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice. Neuroscience 2011, 204:83-89.
3. Carlson G., Wang Y., Alger B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 2002, 5:723-724.
4. Chevaleyre V., Castillo P.E. Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 2004, 43:871-881.
5. Collins D.R., Pertwee R.G., Davies S.N. The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur J Pharmacol 1994, 259:R7-R8.
6. Collins D.R., Pertwee R.G., Davies S.N. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br J Pharmacol 1995, 115:869-870.
7. Conrad C.D., LeDoux J.E., Magariños A.M., McEwen B.S. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci 1999, 113:902-913.
8. Cordero M.I., Venero C., Kruyt N.D., Sandi C. Prior exposure to a single stress session facilitates subsequent contextual fear conditioning in rats. Evidence for a role of corticosterone. Horm Behav 2003, 44:338-345.
9. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.-U., Zieglgänsberger W., Lutz B., Rammes G. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 2006, 26:5794-5799.
10. Feldman R.S., Meyer J.S., Quenzer L.F. Principles of neuropsychopharmacology 1997, Sinauer, Sunderland, MA.
11. Freund T.F. Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci 2003, 26:489-495.
12. Gorzalka B.B., Hill M.N. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1575-1585.
13. Grippo A.J., Johnson A.K. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009, 12:1-21.
14. Herman J.P., Mueller N.K. Role of the ventral subiculum in stress integration. Behav Brain Res 2006, 174:215-224.
15. Hill M.N., Carrier E.J., Ho W.-S.V., Shi L., Patel S., Gorzalka B.B., Hillard C.J. Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus 2008, 18:221-226.
16. Hill M.N., Carrier E.J., McLaughlin R.J., Morrish A.C., Meier S.E., Hillard C.J., Gorzalka B.B. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J Neurochem 2008, 106:2322-2336.
17. Hill M.N., McLaughlin R.J., Bingham B., Shrestha L., Lee T.T.Y., Gray J.M., Hillard C.J., Gorzalka B.B., Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. PNAS 2010, 107:9406-9411.
18. Hill M.N., Patel S., Carrier E.J., Rademacher D.J., Ormerod B.K., Hillard C.J., Gorzalka B.B. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005, 30:508-515.
19. Hoffman A.F., Macgill A.M., Smith D., Oz M., Carl R. Species and strain differences in the expression of a novel glutamate modulating cannabinoid receptor in the rodent hippocampus. Eur J Neurosci 2006, 22:2387-2391.
20. Holderbach R., Clark K., Moreau J.-L., Bischofberger J., Normann C. Enhanced long-term synaptic depression in an animal model of depression. Biol Psychiatry 2007, 62:92-100.
21. Hu W., Zhang M., Czéh B., Zhang W., Flügge G. Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats. Brain Res Bull 2011, 85:374-379.
22. Jankord R., Herman J.P. Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci 2008, 1148:64-73.
23. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
24. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 2006, 26:2991-3001.
25. Kessler R.C., et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety 2010, 27:351-364.
26. Kim J., Alger B.E. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 2010, 13:592-600.
27. Lee T.T., Hill M.N. Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB1 receptor binding in male rats. Neuroscience 2013, 249:106-114.
28. Lee T.T.-Y., Gorzalka B.B. Timing is everything: evidence for a role of corticolimbic endocannabinoids in modulating hypothalamic-pituitary-adrenal axis activity across developmental periods. Neuroscience 2012, 204:17-30.
29. Lenz R.A., Alger B.E. Calcium dependence of depolarization-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons. J Phys 1999, 521(Pt 1):147-157.
30. Marin M.T., Cruz F.C., Planeta C.S. Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats. Physiol Behav 2007, 90:29-35.
31. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 2002, 159:379-387.
32. Misner D.L., Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 1999, 19:6795-6805.
33. Nowicky A.V., Teyler T.J., Vardaris R.M. The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res Bull 1987, 19:663-672.
34. Patel S., Kingsley P.J., Mackie K., Marnett L.J., Winder D.G. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009, 34:2699-2709.
35. Pavlides C., Nivón L.G., McEwen B.S. Effects of chronic stress on hippocampal long-term potentiation. Hippocampus 2002, 12:245-257.
36. Pêgo J.M., Morgado P., Pinto L.G., Cerqueira J.J., Almeida O.F.X., Sousa N. Dissociation of the morphological correlates of stress-induced anxiety and fear. Eur J Neurosci 2008, 27:1503-1516.
37. Reich C.G., Taylor M.E., McCarthy M.M. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav Brain Res 2009, 203:264-269.
38. Reich C.G., Iskander A., Weiss M. Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats. J Psychopharm 2013, 27:947-955.
39. Rossi S., De Chiara V., Musella A., Kusayanagi H., Mataluni G., Bernardi G., Usiello A., Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci 2008, 28:7284-7292.
40. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000, 24:417-463.
41. Sumislawski J.J., Ramikie T.S., Patel S. Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology 2011, 36:2750-2761.
42. Takahashi K.A., Castillo P.E. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 2006, 139:795-802.
43. Terranova J.P., Michaud J.C., Le Fur G., Soubrié P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Pharmacol 1995, 352:576-579.
44. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002, 22:6810-6818.
45. Wamsteeker J.I., Kuzmiski J.B., Bains J.S. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci 2010, 30:11188-11196.
46. Wang M., Hill M.N., Zhang L., Gorzalka B.B., Hillard C.J., Alger B.E. Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J Psychopharmacol 2012, 26:56-70.
47. Wang W., Sun D., Pan B., Roberts C.J., Sun X., Hillard C.J., Liu Q. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology 2010, 35:2249-2261.
48. Wigström H., Gustafsson B. Postsynaptic control of hippocampal long-term potentiation. J Physiol 1986, 81:228-236.
49. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.